Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery
- PMID: 33861408
- DOI: 10.1245/s10434-021-10039-5
Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery
References
-
- Handa Y, Tsutani Y, Mimae T, Miyata Y, Ito H, Shimada Y, et al. Systematic versus lobe-specific mediastinal lymphadenectomy for hypermetabolic lung cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10020-2 . - DOI
-
- Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S-313S. - DOI
-
- Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol. 2014;32(23):2449–55. - DOI
-
- Altorki NK, Yip R, Hanaoka T, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147(2):754–62. (discussion 762–754)
-
- Bott MJ, Cools-Lartigue J, Tan KS, Dycoco J, Bains MS, Downey RJ, Huang J, Isbell JM, Molena D, Park BJ, Rusch VW, Sihag S, Jones DR, Adusumilli PS. Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors. Ann Thorac Surg. 2018;106(1):178–83. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical